View this API's:

Patents at Patent & Trademark Office Patent/Exclusivity data file Drug Approval Drug Safety Freedom of Information Federal Register pages Pharma Companies Pharmacopeial Information Preferred API Supplier (Clients Only)

FDA Approval Activities for this Drug… ADDERALL (Mixed Salts of a Single-Entity Amphetamine Product) Tablets, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg and 30 mg Tablets. Shire Pharmaceutical Development NDA 11-522/S-030 11/8/02 11/19/02 10/9/03 ADDERALL CII (Mixed Salts of a Single-Entity Amphetamine Product) Tablets, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg and 30 mg, Shire Pharmaceutical Development NDA 11-522/S-029 4/11/02 Adderall XR Capsule, Shire NDA 21-303/S1 5/22/02 5/29/02 5/23/02 Adderall XR Capsule, Shire NDA 21-303 Adderall XR (mixed salts of a single-entity amphetamine product) Extended-Release Capsules, Shire, Patient Population Altered   For the latest approval information, locate this drug using this index.